Basic Information
NFL Biosciences is a biopharmaceutical company located in the Montpellier area, developing plant-based candidate drugs for the treatment of addiction. NFL Biosciences aims to bring new, natural, safer, and more effective therapeutic solutions to the entire global population, including low- and middle-income countries. Its most advanced product, NFL-101, is a standardized nicotine-free tobacco leaf extract protected by two patent families. NFL Biosciences intends to provide smokers who want to quit smoking with a natural, safe, easy-to-administer, and personalized alternative. NFL Biosciences is also developing NFL-301, a natural candidate drug aimed at reducing alcohol consumption, and has a drug development program for the treatment of cannabis use disorder.